FDA — authorised 29 December 2005
- Application: NDA021697
- Marketing authorisation holder: CUMBERLAND
- Local brand name: VAPRISOL
- Indication: INJECTABLE — INTRAVENOUS
- Status: approved
🇺🇸 Conivaptan and furosemide in United States
FDA authorised Conivaptan and furosemide on 29 December 2005
Marketing authorisation
Frequently asked questions
Is Conivaptan and furosemide approved in United States?
Yes. FDA authorised it on 29 December 2005.
Who is the marketing authorisation holder for Conivaptan and furosemide in United States?
CUMBERLAND holds the US marketing authorisation.